维普期刊资源整合服务平台（V6.5）

42篇 您的检索式：作者名="Moasser"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	HER3 comes of age: new insights into its functions and role in signaling, tumor biology, and cancer therapy 显示文摘	CAMPBELL MR AMIN D MOASSER MM	2010	Clin Cancer Res2010，16，5：	1
2	The tyrosine kinase inhibitor ZD1839(''Iressa'')inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumor cells 显示文摘	Moasser M M Basso A Averbuch S D	2001	Cancer Res2001，61，：	1
3	Conformation and Structure of Polymeric Contrast Agents for Medical Imaging显示文摘	Uzgiris E E Cline H Moasser B	2004	Biomacromolecules2004，5，：	1
4	The HER family and cancer: emerging molecular mechanisms and therapeutic targets 显示文摘	Sergina NV Moasser MM	2007	Trends Mol Med2007，13，12：	1
5	The role of HER3, the unpretentious member of the HER family,in cancer biolo- gy and cancer therapeutics显示文摘	Amin D N Campbell M R Moasser M M	2010	Semin Cell Dev Biol2010，21，9：	1
6	HER3 comes of age: new insights into its functions and role in signaling,tumor bi- ology,tumor biology, and cancer therapy 显示文摘	Campbell M R Amin D Moasser M M	2010	Clin Cancer Res2010，16，5：	1
7	The oncogene HER2 : Its signaling and transformingfunctions and its role in human cancer pathogenesis 显示文摘	Moasser MM	2007	Onco- gene2007，26，45：	1
8	The tyrosine kinase inhibitor ZD1839 ('Iressa') inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumor cells显示文摘	Moasser MM Basso A Averbuch SD Rosen N	2001	Cancer Res2001，61，：	1
9	The Tyrosine Kinasse Inhibitor ZD1839 (Iressa) Inhibits HER2-driven Signaling and Suppresses the Growth of HER2-overexpressing Turner Cells显示文摘	Moasser MM Basso A Averbuch SD	2001	Cancer Res2001，61，19：	1
10	Targeting the function of the HER2 oncogene in human cancer therapeutics显示文摘	Moasser MM	2007	Oncogene2007，26，46：	1
11	The tyrosine kinase inhibitor ZD1839 ('Iressa') inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumor cells显示文摘	Moasser MM Basso A Averbuch SD		0，，：	1
12	Cellular mechanisms of resistance to an- thracyclines and taxanes in cancer: Intrinsic and acquired 显示文摘	Chien AJ Moasser MM	2008	Semin Oncol2008，35，22：	1
13	lmproved tumor vas- cular function following high dose epidermal growth factor receptor tyrosine kinase inhibitor therapy显示文摘	Moasser M M Wilmes L J Wong C H	2007	J Magn Reson Imaging2007，26，6：	1
14	Targeting the function of the HER2 oncogene in human cancer therapeutics显示文摘	Moasser MM	2007	Oncogene2007，26，46：	1
15	Inhibition of heat shock protein 90 function by ansamycins causes the morphological and functional differentiation of breast cancer cells 显示文摘	Munster PN Srethapakdi M Moasser MM	2001	Cancer Res2001，61，：	1
16	The Evolving Landscape of HER2 Tar- geting in Breast Cancer显示文摘	Mark M Moasser Ian E Krop	2015	JAMA Oncol2015，1，8：	1
17	The oncogene HER2:its signaling and trans- forming functions and its role in human cancer pathogenesis 显示文摘	Moasser MM	2007	Oncogene2007，26，45：	1
18	Targeting the function of the HER-2 oncogene in human cancer therapeutics显示文摘	Moasser M	2007	Oncogene2007，26，46：	1
19	The epidermal growth factor receptor family: biology driving targeted therapeutics 显示文摘	Wieduwilt M J Moasser M M	2008	Cell Mol Life Sci2008，65，10：	1
20	Inhibition of heat shock protein 90 function by ansamycins causes the morphological and functional differentiation of breast cancer cells显示文摘	Münster PN Srethapakdi M Moasser MM	2001	Cancer Res2001，61，7：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示